news
MAP hydrogel biodegradation enhances stem cell growth
A study showed that bone stem cells rearrange degrading microporous annealed particle (MAP) hydrogels, promoting their growth.
List view / Grid view
Stem Cells
news
MS treatment trial to compare stem cell transplantation to biologic drugs
The BEAT-MS trial aims to compare the experimental autologous hematopoietic stem cell transplantation (AHSCT) therapy to the best available biologic therapies for multiple sclerosis (MS).
news
Microcapsules provide targeted chemotherapy drug delivery to cancer cells
Development of infrared light-sensitive microcapsules could be the future in targeted drug delivery for cancer treatment, says new research.
news
NICE recommends Prevymis on the NHS after re-evaluation
The National Institute for Health and Care Excellence is recommending MSD’s Prevymis (letermovir) within the NHS.
news
Stem cells to grow new immune system in Crohn’s disease patients
A phase III clinical trial looks to use a patients own stem cells to treat the debilitating disease...
news
Shimadzu releases C2MAP-2000 automated pretreatment module for cell culture media analysis
Shimadzu Scientific Instruments (SSI) announces the release of the Cell Culture Media Analysis Platform, C2MAPTM-2000, a fully automated and integrated sample preparation workstation for the analysis of cell culture media...
news
Seasonal images reflect stem cells science
University of Southampton postgraduate researcher Catarina Moura creates seasonal images from stem cells as part of her investigation into new optical techniques to monitor the cells' development.
news
GPS-enabled nanoparticles seek and destroy cancer stem cells
Researchers have developed tiny drug-laden nanoparticles that can seek and destroy cancer stem cells...
news
Stem cell therapy shows promise for macular degeneration
Studies show cell-based treatment is safe in patients with dry macular degeneration, with one showing improved vision...
news
Zika virus shown to kill brain cancer stem cells
Research published in The Journal of Experimental Medicine suggests potential treatment for glioblastoma
article
Raman spectroscopy as a blood glucose monitoring tool
European Pharmaceutical Review, Issue 2 of 2016 focused on nanotechnology and stem cell technology to monitor glucose and prevent diabetes, respectively. The aim of this review is to sensitise the technology innovators in this field by providing expert opinions on biomedical products and technologies that have come the closest so…
news
12 months on: European Commission present updates on GDPR timelines and objectives at 7th annual BioBanking Industry Summit
27 April 2017 | By SMi Group
Legal advisor and policy analyst to provide opening keynote on the Impact of the General Data Protection Regulation (GDPR) on collaborative science in Europe.
news
Takeda makes €10 million equity investment in TiGenix
22 December 2016 | By Niamh Louise Marriott, Digital Editor
TiGenix, has exercised the option granted by Takeda under the licensing agreement to make a €10 million equity investment in TiGenix...
whitepaper
Application note: Expansion of human bone marrow-derived mesenchymal stem cells in BioBLU 0.3c single-use bioreactors
16 December 2016 | By Vincent Dufey, Aurélie Tacheny, Muriel Art and Françoise De Longueville, Eppendorf Application Technologies S.A., Namur, Belgium and Ulrike Becken, Eppendorf AG Bioprocess Center, Juelich, Germany
In this application note, Eppendorf discuss how the use of adult stem cells holds great promise for new cell-based therapies and drug discovery...
product
An interview with Lonza’s Minh Hong
Caroline Richards from European Pharmaceutical Review interviews Lonza's Minh Hong to find out more about the L7.
